New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
LB Pharmaceuticals Inc (LBRX) vs Ocular Therapeutix, Inc. (OCUL)
- LB Pharmaceuticals Inc LBRX 38.90 −2.80%
- Ocular Therapeutix, Inc. OCUL 5.70 −2.73%
LB Pharmaceuticals Inc and Ocular Therapeutix, Inc. are both Biotechnology companies. LB Pharmaceuticals Inc and Ocular Therapeutix, Inc. are of similar size ($1.3B and $1.3B). LB Pharmaceuticals Inc has the higher net margin (0.00% vs −648.6%) and the lower return on invested capital (−686.2% vs 0.00%). Across the 13 metrics below, LB Pharmaceuticals Inc leads on 10 and Ocular Therapeutix, Inc. on 3.
Valuation
Profitability
| Metric | LBRX | OCUL | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 87.32% | 70.18% |
| Operating margin | 0.00% | (680.91%) | 0.00% |
| Net margin | 0.00% | (648.64%) | 0.00% |
| Free cash flow margin | 0.00% | (530.00%) | 0.00% |
| Return on equity | (38.80%) | (93.48%) | (51.58%) |
| Return on assets | (36.48%) | (64.30%) | (45.91%) |
| Return on invested capital | (686.18%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack